Cite
Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response.
MLA
Vierling, John M., et al. “Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, Including Prior Null Response.” Journal of Hepatology, vol. 60, no. 4, Apr. 2014, pp. 748–56. EBSCOhost, https://doi.org/10.1016/j.jhep.2013.12.013.
APA
Vierling, J. M., Davis, M., Flamm, S., Gordon, S. C., Lawitz, E., Yoshida, E. M., Galati, J., Luketic, V., McCone, J., Jacobson, I., Marcellin, P., Muir, A. J., Poordad, F., Pedicone, L. D., Albrecht, J., Brass, C., Howe, A. Y. M., Colvard, L. Y., Helmond, F. A., … Bronowicki, J.-P. (2014). Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response. Journal of Hepatology, 60(4), 748–756. https://doi.org/10.1016/j.jhep.2013.12.013
Chicago
Vierling, John M, Mitchell Davis, Steven Flamm, Stuart C Gordon, Eric Lawitz, Eric M Yoshida, Joseph Galati, et al. 2014. “Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, Including Prior Null Response.” Journal of Hepatology 60 (4): 748–56. doi:10.1016/j.jhep.2013.12.013.